Topic: Zometa
STOCKHOLM (Reuters) - Novartis's bone drug zometa" class="inform">Zometa extended survival in older breast cancer patients but failed to improve disease-free survival among younger women patients in a large-scale clinical trial, researchers said on Sunday.Detailed data presented at the European ...
NEW YORK (Reuters) - A U.S. federal jury found that a bone drug made by Novartis Pharmaceuticals Corp was not to blame for the severe jaw deterioration developed by a Rhode Island man who died of cancer in 2005.Karleen Hogan, the ...
Recently, Novartis AG (NVS) presented data from the AZURE trial of its bone drug Zometa at the annual Antonio Breast Cancer Symposium. The Phase...
A major trial that aimed to see if a common bone-strengthening drug could help prevent recurrences of breast cancer found it did not benefit most patients, doctors said Thursday.The five-year study, known as the AZURE trial, followed 3,360 women with ...
Doctors are reporting a stunning setback for a promising new approach for fighting breast cancer.A large study found that the bone-building drug Zometa did not prevent the return of cancer or improve survival in women with early or mid-stage disease.Zometa ...
The FDA has approved Xgeva (denosumab), an osteoporosis drug reformulated to reduce the risk of bone fractures and bone pain in patients with cancer that has spread throughout the body.. The clinical trial results showed Xgeva was more effective overall than Zometa ...
Another shoot of growth sprouted for Amgen (AMGN) Friday as its most important product denosumab won a second US approval - for reducing...
Goldman Sachs is positive on Amgen Inc. (NASDAQ: AMGN ) after the FDA approved its drug Xgeva. It has a Sell rating and a $67 price target on...
Biotech drugmaker Amgen(AMGN) said federal health regulators approved its bone-strengthening drug for preventing fractures and skeletal-problems in...
In the coming days, a few of the largest biotech companies in the U.S. will report their Q3 earnings. Biotech has traditionally been a sector that...
Video Gallery
-
Cancer: Zoledronate/Zoledronic acid (Zometa ) Mech...
Mechanism of action for zoledronic acid/zoledronate (Zometa). EFP Website ...2011-06-20 -
New Zometa Dosing for Patients with ...
Novartis has notified healthcare professionals about new warnings and dosing ...2008-07-14 -
Dr. Berenson on the Study of ...
James R. Berenson, MD, Medical & Scientific Director; Institute for Myeloma & Bone Cancer ...2011-03-15
